IonQ Shares Jump 10.1% on Synopsys Quantum Simulation Research

IBM and IonQ shares rallied Thursday on separate quantum computing developments. IBM's Anderon subsidiary finalized a $1 billion award from the U.S. Department of Commerce under the CHIPS and Science Act, funding research and development at a 300-millimeter quantum wafer facility in Albany, New York, with IBM committing another $1 billion to the project. IonQ, working with NVIDIA, Oak Ridge National Laboratory and the University of Tennessee, developed a generative AI method for producing quantum optimization circuits that maintained a roughly 28-second generation time across tested problem sizes. The two developments mark separate areas of industry progress, with IBM expanding quantum manufacturing capacity while IonQ focuses on reducing computational demands in quantum optimization.

Quantinuum has signed a new non-binding memorandum of understanding with Aramco covering industrial quantum computing, a development that may support expectations for future project demand. The news comes as Quantinuum shares trade at US$52.01, down 21.2% over the past month, leaving investors to weigh how much of that price is supported by book value. On that measure the stock trades at a price-to-book ratio of about 4.6x, against an IT sector average near 2.7x and a peer group around 2.1x. The premium appears tied to expectations that Quantinuum's current asset base could support larger economic opportunities than a typical IT hardware or software group, given the interest the Aramco MoU has raised in its long-term project pipeline. One top community narrative holds that Quantinuum is 61% undervalued, citing Helios systems already in commercial use and a defined road map to Sol in 2027 and Apollo in 2029.

IonQ reported its fifth consecutive record quarter, with second-quarter 2026 adjusted EBITDA of negative $120.3 million, and raised its full-year 2026 revenue guidance to $280 million to $290 million. Days before those results, the company closed a $1.8 billion purchase of SkyWater, and at its September 2026 Investor Day management guided combined 2026 revenue to $450 million to $460 million. Trailing twelve-month revenue is about $250 million, up 370.6% from a year earlier against a three-year average growth rate of 176.4%, while the operating margin stands at -408.2%. IonQ is moving its trapped ion machines from laser control to electronic qubit control, placing ion traps on a semiconductor chip that SkyWater fabricates, with the first fully integrated chips back for testing as the company targets system commissioning in 2027. The stock trades at about $37, roughly 55% below its high inside the last year, and at about $14 billion of market value it commands roughly 54 times its own trailing revenue, which does not include SkyWater.